Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1951 2
1956 2
1959 1
1962 2
1964 3
1965 5
1966 5
1967 5
1968 13
1969 12
1970 11
1971 20
1972 9
1973 11
1974 16
1975 18
1976 19
1977 9
1978 14
1979 16
1980 17
1981 20
1982 17
1983 24
1984 13
1985 20
1986 19
1987 18
1988 18
1989 29
1990 29
1991 33
1992 40
1993 36
1994 43
1995 40
1996 49
1997 66
1998 70
1999 65
2000 78
2001 72
2002 93
2003 95
2004 96
2005 95
2006 97
2007 145
2008 108
2009 140
2010 130
2011 128
2012 132
2013 138
2014 159
2015 119
2016 140
2017 148
2018 199
2019 191
2020 152
2021 12
Text availability
Article attribute
Article type
Publication date

Search Results

3,285 results
Results by year
Filters applied: . Clear all
Page 1
The pharmacotherapeutic management of pediatric Crohn's disease.
Zimmerman L, Bousvaros A. Zimmerman L, et al. Expert Opin Pharmacother. 2019 Dec;20(17):2161-2168. doi: 10.1080/14656566.2019.1659778. Epub 2019 Oct 1. Expert Opin Pharmacother. 2019. PMID: 31574236 Review.
Introduction: Crohn's disease (CD) is a chronic inflammatory condition that can occur throughout the gastrointestinal tract. ...Immunomodulators (thiopurines, methotrexate) and biologics (infliximab, adalimumab) may be employed for maintenance of remission to preven …
Introduction: Crohn's disease (CD) is a chronic inflammatory condition that can occur throughout the gastrointestinal tract. . …
Diet therapy for inflammatory bowel diseases: The established and the new.
Durchschein F, Petritsch W, Hammer HF. Durchschein F, et al. World J Gastroenterol. 2016 Feb 21;22(7):2179-94. doi: 10.3748/wjg.v22.i7.2179. World J Gastroenterol. 2016. PMID: 26900283 Free PMC article. Review.
The role of nutrition in IBD is underscored by the effect of various dietary therapies. In paediatric patients with Crohn's disease (CD) enteral nutrition (EN) reaches remission rates similar to steroids. In adult patients, however, EN is inferior to corticostero
The role of nutrition in IBD is underscored by the effect of various dietary therapies. In paediatric patients with Crohn's diseas
Increasing Infliximab Dose Based on Symptoms, Biomarkers, and Serum Drug Concentrations Does Not Increase Clinical, Endoscopic, and Corticosteroid-Free Remission in Patients With Active Luminal Crohn's Disease.
D'Haens G, Vermeire S, Lambrecht G, Baert F, Bossuyt P, Pariente B, Buisson A, Bouhnik Y, Filippi J, Vander Woude J, Van Hootegem P, Moreau J, Louis E, Franchimont D, De Vos M, Mana F, Peyrin-Biroulet L, Brixi H, Allez M, Caenepeel P, Aubourg A, Oldenburg B, Pierik M, Gils A, Chevret S, Laharie D; GETAID. D'Haens G, et al. Gastroenterology. 2018 Apr;154(5):1343-1351.e1. doi: 10.1053/j.gastro.2018.01.004. Epub 2018 Jan 6. Gastroenterology. 2018. PMID: 29317275 Free article. Clinical Trial.
BACKGROUND & AIMS: A combination of infliximab and immunomodulators is the most efficacious treatment for Crohn's disease (CD). Patients have the best outcomes when their serum concentrations of these drugs are above a determined therapeutic threshold. ...CONCLU …
BACKGROUND & AIMS: A combination of infliximab and immunomodulators is the most efficacious treatment for Crohn's disease
Anti-TNF Therapy in Crohn's Disease.
Adegbola SO, Sahnan K, Warusavitarne J, Hart A, Tozer P. Adegbola SO, et al. Int J Mol Sci. 2018 Jul 31;19(8):2244. doi: 10.3390/ijms19082244. Int J Mol Sci. 2018. PMID: 30065229 Free PMC article. Review.
Crohn's disease (CD) accounts for a variety of clinical manifestations or phenotypes that stem from chronic inflammation in the gastrointestinal tract. Its worldwide incidence is increasing including younger or childhood-onset of disease. The natural history
Crohn's disease (CD) accounts for a variety of clinical manifestations or phenotypes that stem from chronic inflammation in th
Mucosal Healing and Bacterial Composition in Response to Enteral Nutrition Vs Steroid-based Induction Therapy-A Randomised Prospective Clinical Trial in Children With Crohn's Disease.
Pigneur B, Lepage P, Mondot S, Schmitz J, Goulet O, Doré J, Ruemmele FM. Pigneur B, et al. J Crohns Colitis. 2019 Jul 25;13(7):846-855. doi: 10.1093/ecco-jcc/jjy207. J Crohns Colitis. 2019. PMID: 30541015 Clinical Trial.
AIMS: Exclusive enteral nutrition [EEN] is as efficacious as corticosteroids [CS] to induce remission in Crohn's disease [CD], without their adverse effects. ...Patients were assessed at Weeks 0 and 8 using clinical parameters HBI, endoscopic findings (Cro
AIMS: Exclusive enteral nutrition [EEN] is as efficacious as corticosteroids [CS] to induce remission in Crohn's disease
Endoscopic and Radiographic Assessment of Crohn's Disease.
Al-Bawardy B, Hansel SL, Fidler JL, Barlow JM, Bruining DH. Al-Bawardy B, et al. Gastroenterol Clin North Am. 2017 Sep;46(3):493-513. doi: 10.1016/j.gtc.2017.05.005. Gastroenterol Clin North Am. 2017. PMID: 28838411 Review.
Crohn's disease is a chronic inflammatory disorder that can progress to obstructive and penetrating complications. ...The treatment targets have evolved from clinical improvement only to the addition of more objective measures, such as endoscopic mucosal healing and
Crohn's disease is a chronic inflammatory disorder that can progress to obstructive and penetrating complications. ...The trea
Diagnosis and Management of Crohn Disease.
Feld L, Glick LR, Cifu AS. Feld L, et al. JAMA. 2019 May 14;321(18):1822-1823. doi: 10.1001/jama.2019.3684. JAMA. 2019. PMID: 30969326 No abstract available.
[Inflammatory bowel diseases : Crohn's disease and ulcerative colitis].
Fischer S, Rath T, Neurath MF. Fischer S, et al. Internist (Berl). 2018 Jul;59(7):681-693. doi: 10.1007/s00108-018-0442-1. Internist (Berl). 2018. PMID: 29872891 German.
The article is based on a literature search in PubMed and is oriented on the current guidelines published by the European Crohn's and Colitis Organisation. IBD are characterized by chronic diarrhoea, abdominal pain and peranal haemorrhage. ...Early diagnosis and therapeuti …
The article is based on a literature search in PubMed and is oriented on the current guidelines published by the European Crohn's and …
Vedolizumab in Combination With Corticosteroids for Induction Therapy in Crohn's Disease: A Post Hoc Analysis of GEMINI 2 and 3.
Sands BE, Van Assche G, Tudor D, Akhundova-Unadkat G, Curtis RI, Tan T. Sands BE, et al. Inflamm Bowel Dis. 2019 Jul 17;25(8):1375-1382. doi: 10.1093/ibd/izy384. Inflamm Bowel Dis. 2019. PMID: 30615117 Free PMC article. Clinical Trial.
BACKGROUND: Combined therapy with vedolizumab and corticosteroids may improve clinical response or remission in Crohn's disease. The aim of this study is to assess efficacy and safety/tolerability of vedolizumab plus stable doses of corticosteroids at …
BACKGROUND: Combined therapy with vedolizumab and corticosteroids may improve clinical response or remission in Crohn's dis
Steroid Administration and Growth Impairment in Children with Crohn's Disease.
Duchatellier CF, Kumar R, Krupoves A, Braegger C, Herzog D, Amre DK. Duchatellier CF, et al. Inflamm Bowel Dis. 2016 Feb;22(2):355-63. doi: 10.1097/MIB.0000000000000669. Inflamm Bowel Dis. 2016. PMID: 26752463 Free article.
BACKGROUND: Growth impairment remains a major concern in children with Crohn's disease, but evidence remains unclear, in particular, whether steroid use is implicated. ...Cumulative steroid use does not seem to be associated with either TGI or PGI in children with …
BACKGROUND: Growth impairment remains a major concern in children with Crohn's disease, but evidence remains unclear, in parti …
3,285 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback